Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Other Income/Expenses (Net)
-$10.54M
TTM · Period ending: · USD
LCTX Other Income/Expenses (Net)
Latest reported-$10.54Mperiod ending
Latest reported-$10.54Mperiod ending
LCTX TTM Other Income/Expenses (Net) ($300.00K → -$10.54M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
LCTX other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -10,535,000 | |
| -31,586,000 | |
| -32,028,000 | |
| -32,328,000 | |
| -5,523,000 | |
| 5,155,000 | |
| 2,896,000 | |
| 2,684,000 | |
| 1,392,000 | |
| 1,119,000 | |
| 1,451,000 | |
| 80,000 | |
| 209,000 | |
| -2,160,000 | |
| -3,292,000 | |
| -3,340,000 | |
| -5,019,000 | |
| -356,000 | |
| 5,943,000 | |
| 12,580,000 | |
| 13,358,000 | |
| 11,115,000 | |
| 4,523,000 | |
| -811,000 | |
| -8,670,000 | |
| -29,021,000 | |
| 19,642,000 | |
| -17,005,000 | |
| 68,980,000 | |
| 93,957,000 | |
| -5,227,000 | |
| -37,393,000 | |
| -86,023,000 | |
| -96,307,000 | |
| 17,367,000 | |
| 88,161,000 | |
| 98,710,000 | |
| 140,124,000 | |
| 77,722,000 | |
| 77,983,000 | |
| 38,578,000 | |
| 3,179,000 | |
| 3,153,063 | |
| -1,195,340 | |
| -736,340 | |
| -810,340 | |
| -484,617 | |
| 47,510 | |
| 119,145 | |
| -115,017 | |
| -204,439 | |
| -240,194 | |
| -162,890 | |
| -2,014 | |
| -292,175 | |
| -140,022 | |
| 331,778 | |
| 953,130 | |
| 1,935,682 | |
| -1,759,232 | |
| 203,733 | |
| -443,684 | |
| -1,068,081 | |
| 2,566,686 | |
| -531,432 | |
| -950,801 | |
| -1,597,118 | |
| -643,070 | |
| -165,997 | |
| 484,279 | |
| 1,022,262 | |
| 311,634 | |
| 417,150 | |
| 80,315 | |
| 111,061 | |
| 193,789 | |
| 221,069 | |
| 244,684 | |
| 265,798 | |
| -23,205 | |
| -4,018 | |
| 7,086 | |
| 23,138 | |
| -26,179 | |
| -1,406 | |
| 19,830 | |
| -1,116,550 | |
| -1,109,889 | |
| -403,962 | |
| -669,116 | |
| 262,881 | |
| 863,417 | |
| -117,192 | |
| -67,607 | |
| 137,840 | |
| -471,160 | |
| -209,893 | |
| 0 | |
| 0 | |
| 0 |